{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:45:01Z","timestamp":1792269901705,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.drudis.2014.03.016","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T20:33:18Z","timestamp":1395520398000},"page":"956-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis"],"prefix":"10.1016","volume":"19","author":[{"given":"Amit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Vaish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv R.","family":"Ratan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2014.03.016_bib0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neuron in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.drudis.2014.03.016_bib0010","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.8303297","article-title":"Transcriptional activation modulated by homopolymeric glutamine and proline stretches","volume":"263","author":"Gerber","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.drudis.2014.03.016_bib0015","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuritis in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.drudis.2014.03.016_bib0020","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","article-title":"Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus","volume":"17","author":"Warby","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0025","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/hmg\/ddr023","article-title":"Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation","volume":"20","author":"Havel","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0030","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1074\/jbc.M112.413575","article-title":"An N-terminal nuclear export signal regulates trafficking and aggregation of huntingtin (Htt) protein exon 1","volume":"288","author":"Zheng","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2014.03.016_bib0040","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","article-title":"Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice","volume":"13","author":"Schilling","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0045","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/hmg\/ddi340","article-title":"Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease","volume":"14","author":"Benn","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0050","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0055","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","article-title":"Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo","volume":"30","author":"Graham","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0060","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1566-2772(03)00059-8","article-title":"Mechanisms of transcriptional dysregulation in Huntington's disease","volume":"3","author":"Luthi-Carter","year":"2003","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.drudis.2014.03.016_bib0075","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and non-pathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.03.016_bib0080","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with CBP mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.drudis.2014.03.016_bib0085","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1111\/j.1460-9568.2006.04871.x","article-title":"Huntingtin inclusions do not downregulate specific genes in the R6\/2 Huntington's disease mouse","volume":"23","author":"Sadri-Vakili","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0090","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","article-title":"Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice","volume":"11","author":"Yu","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0095","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.drudis.2014.03.016_bib0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","article-title":"Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease","volume":"22","author":"Chen-Plotkin","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2014.03.016_bib0105","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1074\/jbc.M511648200","article-title":"Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective","volume":"281","author":"Qiu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0110","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0115","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1523\/JNEUROSCI.0710-11.2011","article-title":"Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration","volume":"31","author":"Sleiman","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0120","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","article-title":"Decreased cAMP response element mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis","volume":"279","author":"Sugars","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2014.03.016_bib0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/emmm.201000084","article-title":"Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease","volume":"2","author":"McConoughey","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.drudis.2014.03.016_bib0135","doi-asserted-by":"crossref","first-page":"40398","DOI":"10.1074\/jbc.C500140200","article-title":"Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2014.03.016_bib0145","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"Giralt","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","article-title":"Mechanisms of disease: histone modifications in Huntington's disease","volume":"2","author":"Sadri-Vakili","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.drudis.2014.03.016_bib0155","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1042\/BST0371270","article-title":"Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease","volume":"37","author":"Bithell","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drudis.2014.03.016_bib0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.drudis.2014.03.016_bib0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0170","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington's disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2014.03.016_bib0175","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease","volume":"28","author":"Packer","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12031-012-9739-z","article-title":"Sp1 regulates human huntingtin gene expression","volume":"47","author":"Wang","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0185","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1083\/jcb.153.2.283","article-title":"Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression","volume":"153","author":"Suhr","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drudis.2014.03.016_bib0195","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2014.03.016_bib0200","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0205","doi-asserted-by":"crossref","first-page":"e41423","DOI":"10.1371\/journal.pone.0041423","article-title":"Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease","volume":"7","author":"McFarland","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2014.03.016_bib0210","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.03.016_bib0215","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.03.016_bib0220","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1523\/JNEUROSCI.5667-07.2008","article-title":"Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation","volume":"28","author":"Kim","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0225","doi-asserted-by":"crossref","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","article-title":"Targeting H3K4 trimethylation in Huntington disease","volume":"110","author":"Vashishtha","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.03.016_bib0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1471-4159.2008.05350.x","article-title":"Increased levels of gamma-glutamylamines in Huntington disease CSF","volume":"106","author":"Jeitner","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0235","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","article-title":"Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner","volume":"28","author":"Benn","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0240","doi-asserted-by":"crossref","first-page":"e41152","DOI":"10.1371\/journal.pone.0041152","article-title":"Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression","volume":"7","author":"Hogel","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2014.03.016_bib0245","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0250","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0255","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbadis.2009.06.008","article-title":"Impaired mitochondrial trafficking in Huntington's disease","volume":"1802","author":"Li","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2014.03.016_bib0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mad.2005.09.010","article-title":"Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for huntington disease mutation","volume":"127","author":"Squitieri","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.drudis.2014.03.016_bib0265","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00109-007-0283-1","article-title":"Harnessing hypoxic adaptation to prevent, treat, and repair stroke","volume":"85","author":"Ratan","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.drudis.2014.03.016_bib0270","doi-asserted-by":"crossref","first-page":"142ra97","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1\u03b1 rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"Tsunemi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drudis.2014.03.016_bib0275","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2006.09.006","article-title":"Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity","volume":"25","author":"DeMarch","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2014.03.016_bib0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nbd.2009.02.014","article-title":"Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease","volume":"34","author":"Giampa","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2014.03.016_bib0285","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.12348","article-title":"Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models","author":"Conforti","year":"2013","journal-title":"J. Neurochem"},{"key":"10.1016\/j.drudis.2014.03.016_bib0290","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/gt.2012.84","article-title":"In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice","volume":"20","author":"Conforti","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2014.03.016_bib0295","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-4159.2010.07122.x","article-title":"Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease","volume":"116","author":"Soldati","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0300","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-\u03b3 agonist rosiglitazone in N171-82Q mouse model of Huntington's disease","volume":"125","author":"Jin","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2014.03.016_bib0305","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","article-title":"Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway","volume":"100","author":"Ryu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.03.016_bib0310","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0315","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1523\/JNEUROSCI.3344-05.2006","article-title":"Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity","volume":"26","author":"Bates","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.03.016_bib0320","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease","volume":"17","author":"Pallos","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2014.03.016_bib0325","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.03.016_bib0330","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.celrep.2012.11.001","article-title":"The Sirtuin 2 inhibitor AK-7 is neuroprotective in huntington disease mouse models","volume":"2","author":"Chopra","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.drudis.2014.03.016_bib0335","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","article-title":"Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington's disease","volume":"41","author":"Hathorn","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2014.03.016_bib0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.conb.2011.01.002","article-title":"The influence of synaptic activity on neuronal health","volume":"21","author":"Bell","year":"2011","journal-title":"Curr. Opin. Neurobiol."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644614000932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644614000932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:18:22Z","timestamp":1761221902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644614000932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1359644614000932"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2014.03.016","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2014.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}